SUPN
Supernus Pharmaceuticals, Inc. - Common Stock (SUPN)
$96
About Supernus Pharmaceuticals, Inc. - Common Stock (SUPN)
Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. It offers Trokendi XR, Oxtellar XR, APOKYN, XADAGO, and MYOBLOC products. The company was founded by Jack A. Khattar on March 30, 2005, and is headquartered in Rockville, MD.
Details
Daily high
$33.26
Daily low
$32.01
Price at open
$32.33
52 Week High
$40.28
52 Week Low
$25.55
Market cap
1.8B
Dividend yield
0.00%
Volume
583,113
Avg. volume
540,449
P/E ratio
29.84
Supernus Pharmaceuticals, Inc. - Common Stock News
Details
Daily high
$33.26
Daily low
$32.01
Price at open
$32.33
52 Week High
$40.28
52 Week Low
$25.55
Market cap
1.8B
Dividend yield
0.00%
Volume
583,113
Avg. volume
540,449
P/E ratio
29.84